Evidence map›Paper›PMID 38372210›Full record

ReviewMolecular microbiology2024

Bacteriophage lambda site-specific recombination.

Gregory D Van Duyne, Arthur Landy

Abstract readReview
In one paragraph

Review in Molecular microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Structural basis of directionality control in large serine integrases.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Dynamics in Cre-loxP site-specific recombination.Current opinion in structural biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gregory D Van DuyneDepartment of Biochemistry & Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-0247-1626
Arthur LandyDepartment of Molecular Biology, Cell Biology, and Biochemistry, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.

Funding

MECHANISMS OF SITE SPECIFIC RECOMBINATIONR01GM062723 · NIGMS · BROWN UNIVERSITY · PI LANDY, ARTHUR · 2000 to 2012
$6.4M
RECOMBINATION INTERMEDIATES-- PROPERTIES &PROCESSINGR01GM033928 · NIGMS · BROWN UNIVERSITY · PI LANDY, ARTHUR · 1985 to 2011
$6.2M
Serine integrase mechanisms and applicationsR01GM108751 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI VAN DUYNE, GREGORY D · 2014 to 2024
$2.5M
NIGMS NIH HHS GM033928NIGMS NIH HHS GM062723NIGMS NIH HHS GM108751NIGMS NIH HHS R01 GM033928NIGMS NIH HHS R01 GM062723NIGMS NIH HHS R01 GM108751
6 · The paper itself

Abstract

The site-specific recombination pathway of bacteriophage λ encompasses isoenergetic but highly directional and tightly regulated integrative and excisive reactions that integrate and excise the vial chromosome into and out of the bacterial chromosome. The reactions require 240 bp of phage DNA and 21 bp of bacterial DNA comprising 16 protein binding sites that are differentially used in each pathway by the phage-encoded Int and Xis proteins and the host-encoded integration host factor and factor for inversion stimulation proteins. Structures of higher-order protein-DNA complexes of the four-way Holliday junction recombination intermediates provided clarifying insights into the mechanisms, directionality, and regulation of these two pathways, which are tightly linked to the physiology of the bacterial host cell. Here we review our current understanding of the mechanisms responsible for regulating and executing λ site-specific recombination, with an emphasis on key studies completed over the last decade.

Indexed as

Bacteriophage lambdaRecombination, GeneticBinding SitesDNA, BacterialDNA, ViralIntegration Host FactorsViral ProteinsDNA, BacterialDNA, ViralIntegration Host FactorsViral Proteinsbacteriophage lambdaDNA bendingHolliday junctionintegrationsite‐specific recombinationtyrosine recombinaseviral excisionviral integration

Identifiers

PMID38372210
PMCPMC11096046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.